Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Zapata Quantum, Inc.ZPTA · Entity 6486 | Director · CEO and President | March 28, 2024 | April 01, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Zapata Quantum, Inc.
Report date March 28, 2024 · Filed April 01, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 687,026 |
Reported balance
After 2024-03-28 transaction · row 1
1 source rowRow 1 · 2024-03-28 · Grant · Acquired 687,026 · Balance 687,026 F1: Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement"), dated as of September 6, 2023, by and among Andretti Acquisition Corp., Tigre Merger Sub, Inc. and Zapata Computing, Inc. ("Private Zapata"), in exchange for 751,572 shares of common stock of Private Zapata. |
| Common StockSEC Table I · non-derivative | Indirectby spouse | 109,694 |
Reported balance
After 2024-03-28 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2024-03-28 · Grant · Acquired 109,694 · Balance 109,694 F2: Received in accordance with the terms of the Business Combination Agreement in exchange for 120,000 shares of common stock of Private Zapata previously held by the Reporting Person's spouse. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.25 · Expires 2029-05-22 | Direct | 345,589 |
Reported balance
After 2024-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-03-28 · Grant · Acquired 345,589 · Balance 345,589 F4: Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 378,057 shares of common stock of Private Zapata at a purchase price of $1.14 per share. F3: 100% of the shares subject to the option are fully vested and exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.02 · Expires 2031-03-24 | Direct | 433,007 |
Reported balance
After 2024-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-03-28 · Grant · Acquired 433,007 · Balance 433,007 F6: Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 473,688 shares of common stock of Private Zapata at a purchase price of $1.84 per share. F5: The option became or will become exercisable over four years from March 1, 2021, with 25% vested on March 1, 2022 and the remainder vesting in equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement"), dated as of September 6, 2023, by and among Andretti Acquisition Corp., Tigre Merger Sub, Inc. and Zapata Computing, Inc. ("Private Zapata"), in exchange for 751,572 shares of common stock of Private Zapata.
F2: Received in accordance with the terms of the Business Combination Agreement in exchange for 120,000 shares of common stock of Private Zapata previously held by the Reporting Person's spouse.
F3: 100% of the shares subject to the option are fully vested and exercisable.
F4: Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 378,057 shares of common stock of Private Zapata at a purchase price of $1.14 per share.
F5: The option became or will become exercisable over four years from March 1, 2021, with 25% vested on March 1, 2022 and the remainder vesting in equal monthly installments thereafter.
F6: Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 473,688 shares of common stock of Private Zapata at a purchase price of $1.84 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2024 Filed Apr 1, 2024 13:22 UTC | Zapata Quantum, Inc. ZPTA · Entity 6486 | GrantStock Option (Right to Buy) · Derivative | 433,007 | Not disclosed Strike: $2.02 | Not disclosed |
DisclosureSEC source: 0001062993-24-007514 · form4.xml · derivative · entry 4 Savoie Christopher · CIK 0002010727 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 433,007 Underlying: Common Stock · 433,007 shares Expires 2031-03-24 F6 · price: Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 473,688 shares of common stock of Private Zapata at a purchase price of $1.84 per share. F5 · derivative.exercise_date: The option became or will become exercisable over four years from March 1, 2021, with 25% vested on March 1, 2022 and the remainder vesting in equal monthly installments thereafter. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 13:22 UTC | Zapata Quantum, Inc. ZPTA · Entity 6486 | GrantStock Option (Right to Buy) · Derivative | 345,589 | Not disclosed Strike: $1.25 | Not disclosed |
DisclosureSEC source: 0001062993-24-007514 · form4.xml · derivative · entry 3 Savoie Christopher · CIK 0002010727 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 345,589 Underlying: Common Stock · 345,589 shares Expires 2029-05-22 F4 · price: Received in accordance with the terms of the Business Combination Agreement in exchange for an option to acquire 378,057 shares of common stock of Private Zapata at a purchase price of $1.14 per share. F3 · derivative.exercise_date: 100% of the shares subject to the option are fully vested and exercisable. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 13:22 UTC | Zapata Quantum, Inc. ZPTA · Entity 6486 | GrantCommon Stock | 109,694 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-007514 · form4.xml · nonDerivative · entry 2 Savoie Christopher · CIK 0002010727 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Indirect · by spouse Disclosed balance after: 109,694 F2 · price: Received in accordance with the terms of the Business Combination Agreement in exchange for 120,000 shares of common stock of Private Zapata previously held by the Reporting Person's spouse. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 13:22 UTC | Zapata Quantum, Inc. ZPTA · Entity 6486 | GrantCommon Stock | 687,026 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-007514 · form4.xml · nonDerivative · entry 1 Savoie Christopher · CIK 0002010727 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 687,026 F1 · price: Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement"), dated as of September 6, 2023, by and among Andretti Acquisition Corp., Tigre Merger Sub, Inc. and Zapata Computing, Inc. ("Private Zapata"), in exchange for 751,572 shares of common stock of Private Zapata. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.